
Novel CAR T Therapy Earns FDA Breakthrough Status for Incurable Pediatric Brain Tumor
The FDA has granted breakthrough therapy designation to BCB-276 for the treatment of diffuse intrinsic pontine glioma (DIPG), an incurable pediatric brain tumor. BCB-276 is an investigational chimeric antigen receptor (CAR) T-cell therapy targeting B7-H3. …